News
Tempus AI, Inc. (NASDAQ:TEM) investors will be delighted, with the company turning in some strong numbers with its latest results. Results overall were solid, with revenues arriving 5.7% better than ...
Alphabet, UnitedHealth Group, Salesforce, Oracle, ServiceNow, Palo Alto Networks, and Tempus AI are the seven Healthcare ...
Growth of 22% in advertising services is driving margin expansion for Amazon's retail divisions. Over the last 12 months, North American retail has an operating margin of 7% and international a margin ...
Q2 2025 Earnings Conference Call August 8, 2025 8:00 PM ETCompany ParticipantsElizabeth Krutoholow - Vice President of ...
3d
TipRanks on MSNTEM Earnings: Tempus AI Stock (TEM) ‘Hitting its Stride’ on Soaring AI Drug Demand
Shares in health technology group Tempus AI ($TEM) raced 7% higher today after its Q2 revenues surged on cancer testing demand. Forecast Busting ...
The stock of Tempus AI (NASDAQ: TEM) gave back some of its gains after surging early in Friday's trading, but it still ended ...
In trading on the Nasdaq stock market as of 1:17 p.m. Central, Tempus' stock price was trading at $60.65, up 3.2% from the ...
Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday. The AI-focused precision medicine and patient ...
Discover Tempus AI's impressive Q2 2025 results: 89.6% revenue growth, stronger guidance, robust data deals, and strides toward breakeven.
These 10 stocks could mint the next wave of millionaires › Tempus AI (NASDAQ:TEM), a technology company that applies artificial intelligence to precision diagnostics and healthcare data, reported its ...
The firm's genomics revenues more than doubled year over year, while data and services revenue increased nearly 36 percent.
3d
Zacks Investment Research on MSNTEM's Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
Tempus AI, Inc. TEM reported a second-quarter 2025 adjusted loss of 22 cents per share, narrower than the Zacks Consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results